Patrick Fisher

Patrick Fisher joined the Orthofix Executive Leadership Team in 2024 as the President of Global Limb Reconstruction and expanded his scope in 2026 to include oversight of the company’s Biologics business.  

Mr. Fisher previously served as Vice President and General Manager of the Foot and Ankle business unit with Stryker Corporation, a global medical technology company. Prior to his tenure at Stryker, Mr. Fisher served as the President of Lower Extremity and Biologics for Wright Medical Technology, which was acquired by Stryker in 2020. He joined Wright Medical in 2002 and held multiple roles of increasing responsibility including Vice President of U.S. Sales. 

Mr. Fisher has a proven track record of driving revenue growth, expanding EBITDA, and transforming operations within medium to large publicly traded companies. His expertise spans global marketing, R&D, sales, clinical research, and medical education, with a strong focus on integrity, ethics, and quality compliance. 

Mr. Fisher has a Bachelor of Arts in International Studies from Rhodes College and a Master of Business Administration in International Business from the University of Memphis. Mr. Fisher serves on several boards, including CurveBeam AI as an independent non-executive director, the University of Tennessee Research Advisory Board, and the Mission 3A Healthcare Advisory Board.